PRTG and gastric cancer: Therefore, our findings thus provide new insights into the molecular mechanisms involved in H. pylori-mediated gastric cancer progression and suggests that blocking PRTG activation by antagonizing cGMP-PKG signaling through compounds such as KT5823 could provide a novel therapeutic approach to treat gastric cancer.